Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M 4 muscarinic acetylcholine receptor knockout mice
- 31 August 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (18) , 10483-10488
- https://doi.org/10.1073/pnas.96.18.10483
Abstract
Muscarinic acetylcholine receptors (M 1 –M 5 ) regulate many key functions of the central and peripheral nervous system. Primarily because of the lack of receptor subtype-selective ligands, the precise physiological roles of the individual muscarinic receptor subtypes remain to be elucidated. Interestingly, the M 4 receptor subtype is expressed abundantly in the striatum and various other forebrain regions. To study its potential role in the regulation of locomotor activity and other central functions, we used gene-targeting technology to create mice that lack functional M 4 receptors. Pharmacologic analysis of M 4 receptor-deficient mice indicated that M 4 receptors are not required for muscarinic receptor-mediated analgesia, tremor, hypothermia, and salivation. Strikingly, M 4 receptor-deficient mice showed an increase in basal locomotor activity and greatly enhanced locomotor responses (as compared with their wild-type littermates) after activation of D1 dopamine receptors. These results indicate that M 4 receptors exert inhibitory control on D1 receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons where the two receptors are coexpressed at high levels. Our findings offer new perspectives for the treatment of Parkinson’s disease and other movement disorders that are characterized by an imbalance between muscarinic cholinergic and dopaminergic neurotransmission.Keywords
This publication has 40 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonistLife Sciences, 1997
- Molecular Biology of Muscarinic Acetylcholine ReceptorsCritical Reviews™ in Neurobiology, 1996
- Lethal α–thalassaemia created by gene targeting in mice and its genetic rescueNature Genetics, 1995
- D2 Receptor Antagonists Do Not Modify Guanine Nucleotide‐Sensitive Interactions Between Dopamine and D1 Dopamine Receptors Under In Vitro ConditionsJournal of Neurochemistry, 1995
- The background of the muscarinic systemLife Sciences, 1995
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Molecular biology of dopamine receptorsTrends in Pharmacological Sciences, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Antinociception opioids and the cholinergic systemProgress in Neurobiology, 1986